Management of neurofibromatosis type 2

被引:0
|
作者
Vincent, C [1 ]
Angot, A [1 ]
Louis, E [1 ]
Lejeune, JP [1 ]
Vaneecloo, FM [1 ]
机构
[1] Ctr Hosp Reg & Univ Lille, Hop R Salengro, Serv Otol & Otoneurol, F-59037 Lille, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neurofibromatosis type 2 (NF2) is characterized by bilateral eighth cranial nerve schwannomas although some patients may have also other spinal and intracranial tumors. The disease has an autosomal-dominant mode of inheritance. The relationships between the heterogeneity within the NF2 gene mutations and the severity of the phenotype are not yet perfectly defined. The aim of the study is to report on our series of 13 patients with NF2 managed by our two departments in close collaboration. Treatment options have included observation, surgical intervention for complete tumor removal: middle fossa approach, retrosigmoid approach, combined middle fossa and retrosigmoid approach, translabyrinthine approach and translabyrinthine approach with auditory brainstem implantation.
引用
收藏
页码:727 / 731
页数:3
相关论文
共 50 条
  • [41] Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2
    Tan, Haoyue
    Jia, Huan
    Li, Yun
    Zhang, Zhihua
    Zhu, Weidong
    Cai, Yun
    Wang, Zhaoyan
    Wu, Hao
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (11) : 2667 - 2674
  • [42] Anaesthetic Management of a Child with Neurofibromatosis Type 2 for Multiple Tumour Decompressions
    Lakshiminarasimhaiah, Geetha
    Jagannatha, Aniruddha Thekkatte
    Pai, Ku Yadi Raghavendra
    Varma, Ravi Gopal
    Hegde, Alangar Satyaranjandas
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (12) : 3004 - 3005
  • [43] Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]
    Evans, D. Gareth R.
    GENETICS IN MEDICINE, 2009, 11 (09) : 599 - 610
  • [44] A case of type 2 neurofibromatosis
    Filip, M.
    Socoliuc, C.
    Bastian, A.
    Craciun, M.
    Raduta, D.
    Ignat, E.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S316 - S316
  • [45] NEUROFIBROMATOSIS TYPE-2
    EVANS, DGR
    HARRIS, R
    SAUDI MEDICAL JOURNAL, 1994, 15 (01) : 26 - 30
  • [46] Multifocality in neurofibromatosis type 2
    Evans, D. Gareth R.
    Stivaros, Stavros M.
    NEURO-ONCOLOGY, 2015, 17 (04) : 481 - 482
  • [47] NEUROFIBROMATOSIS TYPE-2
    THOMAS, G
    MEREL, P
    SANSON, M
    HOANGXUAN, K
    ZUCMAN, J
    DESMAZE, C
    MELOT, T
    AURIAS, A
    DELATTRE, O
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (13) : 1981 - 1987
  • [48] Pseudopapilledema in neurofibromatosis type 2
    Lueder, GT
    Doll, JT
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 129 (03) : 405 - 407
  • [49] Management of orbital dystopia in neurofibromatosis type I
    Sakamoto, Yoshiaki
    Miwa, Tomoru
    Toda, Masahiro
    Kishi, Kazuo
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2021, 74 (12): : 3471 - 3472
  • [50] Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service
    Smith, Matthew E.
    Edmiston, Rachel
    Trudel, Mathieu
    Freeman, Simon
    Stapleton, Emma
    Axon, Patrick
    Donnelly, Neil
    Tysome, James R.
    Bance, Manohar
    Obholzer, Rupert
    Jiang, Dan
    Mackeith, Samuel
    Ramsden, James
    O'Driscoll, Martin
    Mawman, Deborah
    Buttimore, Juliette
    Nunn, Terry
    Humphries, Jane
    Evans, Dafydd Gareth
    Lloyd, Simon K. W.
    OTOLOGY & NEUROTOLOGY, 2022, 43 (05) : 538 - 546